Skip to main content

Table 5 Multivariate model (N = 1510) describing factors associated with receipt of severe malaria drugs

From: Management of uncomplicated malaria among children under five years at public and private sector facilities in Mali

Variable

OR

95% CI

p

Type of health facility

 Public urban

1.00

–

–

 Public rural

6.34

0.15, 266

0.333

 Community health worker

0.07

0.003, 1.35

0.078

 Private

0.16

0.01, 4.20

0.273

Parasitological testing

 Negative test result

1.00

–

–

 Positive test result

4.84

2.84, 8.26

< 0.001

 Not tested

3.65

2.03, 6.56

< 0.001

Axillary temperature of child

  < 37.5 °C

1.00

–

–

 37.5–38.4 °C

2.30

1.61, 3.28

< 0.001

 38.5–39.4 °C

4.40

2.94, 6.59

< 0.001

  ≥ 39.5 °C

8.78

4.85, 15.89

< 0.001

Age of child in years (increasing)

1.24

1.11, 1.38

< 0.001

  1. Severe malaria drugs included are injectable artemether, artesunate or quinine. Where reported drug was artemether with formulation unspecified (n = 171), the formulation was assumed to be injectable